PRODUCT ADMINISTRATION ISSUE

PRODUCT ADMINISTRATION ISSUE was reported 209 times

These drug classes are most commonly taken by patients reporting PRODUCT ADMINISTRATION ISSUE:

# Drug Count
0 Proton Pump Inhibitor [EPC] 49
1 Atypical Antipsychotic [EPC] 46
2 Nonsteroidal Anti-inflammatory Drug [EPC] 39
3 Benzodiazepine [EPC] 36
4 Mood Stabilizer [EPC] 34
5 Tetracycline-class Drug [EPC] 26
6 Angiotensin 2 Receptor Blocker [EPC] 24
7 Tumor Necrosis Factor Blocker [EPC] 24
8 Vitamin C [EPC] 24
9 Dietary Cholesterol Absorption Inhibitor [EPC] 23
10 Histamine-1 Receptor Antagonist [EPC] 23
11 Methylxanthine [EPC] 23
12 Vitamin B12 [EPC] 22
13 Vitamin D [EPC] 22
14 Ergot Derivative [EPC] 21
15 Folate Analog Metabolic Inhibitor [EPC] 19
16 Muscle Relaxant [EPC] 19
17 Fluoroquinolone Antibacterial [EPC] 16
18 Anti-epileptic Agent [EPC] 14
19 Nitrogen Binding Agent [EPC] 14
20 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 11
21 Loop Diuretic [EPC] 10
22 Osmotic Laxative [EPC] 10
23 gamma-Aminobutyric Acid-ergic Agonist [EPC] 9
24 CD20-directed Cytolytic Antibody [EPC] 8
25 Interleukin-13 Antagonist [EPC] 8
26 HMG-CoA Reductase Inhibitor [EPC] 6
27 Provitamin D2 Compound [EPC] 6
28 Purine Antimetabolite [EPC] 6
29 Corticosteroid [EPC] 5
30 Estrogen [EPC] 5
31 Insulin Analog [EPC] 5
32 Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] 5
33 Recombinant Human Growth Hormone [EPC] 5
34 Calcium [EPC] 4
35 Interleukin-23 Antagonist [EPC] 4
36 Interleukin-4 Receptor alpha Antagonist [EPC] 4
37 Phosphodiesterase 4 Inhibitor [EPC] 4
38 Progesterone [EPC] 4
39 Alkylating Drug [EPC] 3
40 Factor Xa Inhibitor [EPC] 3
41 GLP-1 Receptor Agonist [EPC] 3
42 Phosphodiesterase 3 Inhibitor [EPC] 3
43 Potassium Salt [EPC] 3
44 Arteriolar Vasodilator [EPC] 2
45 Complement Inhibitor [EPC] 2
46 Dopamine-2 Receptor Antagonist [EPC] 2
47 Kinase Inhibitor [EPC] 2
48 Opioid Agonist [EPC] 2
49 Platelet Aggregation Inhibitor [EPC] 2
50 Tissue-nonspecific Alkaline Phosphatase [EPC] 2
51 beta-Adrenergic Blocker [EPC] 2
52 Aminoglycoside Antibacterial [EPC] 1
53 Anti-IgE [EPC] 1
54 Antimalarial [EPC] 1
55 Antiprotozoal [EPC] 1
56 Antisense Oligonucleotide [EPC] 1
57 Aromatase Inhibitor [EPC] 1
58 Aromatic Amino Acid [EPC] 1
59 Azole Antifungal [EPC] 1
60 CD22-directed Immunoconjugate [EPC] 1
61 Cannabinoid [EPC] 1
62 Cardiac Myosin Inhibitor [EPC] 1
63 Catechol-O-Methyltransferase Inhibitor [EPC] 1
64 Catecholamine [EPC] 1
65 Central Nervous System Stimulant [EPC] 1
66 Cholinergic Muscarinic Agonist [EPC] 1
67 Estrogen Receptor Antagonist [EPC] 1
68 Expectorant [EPC] 1
69 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
70 Human Immunoglobulin G [EPC] 1
71 Influenza A M2 Protein Inhibitor [EPC] 1
72 Integrin Receptor Antagonist [EPC] 1
73 Interleukin-17A Antagonist [EPC] 1
74 Interleukin-5 Antagonist [EPC] 1
75 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1
76 Janus Kinase Inhibitor [EPC] 1
77 Melatonin Receptor Agonist [EPC] 1
78 Non-Standardized Chemical Allergen [EPC] 1
79 Non-Standardized Food Allergenic Extract [EPC] 1
80 Non-Standardized Plant Allergenic Extract [EPC] 1
81 Phosphodiesterase 5 Inhibitor [EPC] 1
82 Polyene Antifungal [EPC] 1
83 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
84 Radiographic Contrast Agent [EPC] 1
85 Rifamycin Antibacterial [EPC] 1
86 Sodium Channel Blocker [EPC] 1
87 Survival of Motor Neuron 2 Splicing Modifier [EPC] 1
88 Thymic Stromal Lymphopoietin Blocker [EPC] 1
89 Vitamin K [EPC] 1
90 Warfarin Reversal Agent [EPC] 1
91 Xanthine Oxidase Inhibitor [EPC] 1
92 alpha-Adrenergic Agonist [EPC] 1
93 beta-Adrenergic Agonist [EPC] 1